Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (21-30 of 375) with videos related to

Pageof 38
Sort By:
Breast Cancer Research and Treatment|June 30, 2020
Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancerMarta Perachino, Francesca Poggio, Matteo Lambertini
Breast (Edinburgh, Scotland)|May 20, 2026
Neurokinin pathway antagonists for vasomotor symptoms in women with breast cancer: focus on elinzanetant and fezolinetantKatarzyna Pogoda, Luca Arecco, Matteo Lambertini
BJC Reports|September 20, 2025
Response to: Survival after risk-reducing mastectomy in young BRCA1 carriers with breast cancerVirginia Delucchi, Matteo Lambertini, Eva Blondeaux
Journal of Thoracic Disease|July 1, 2014
The burden of breast cancer from China to ItalyAlessia Levaggi, Francesca Poggio, Matteo Lambertini
Breast Cancer Research and Treatment|May 11, 2018
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapyFrancesca Poggio, Benedetta Conte, Matteo Lambertini
Current Opinion in Oncology|October 10, 2018
Impact of ovarian function suppression in premenopausal women with estrogen receptor-positive early breast cancerMatteo Lambertini, Giulia Viglietti, Evandro de Azambuja
NPJ Breast Cancer|March 17, 2023
Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancerElisa Agostinetto, Evandro de Azambuja, Matteo Lambertini
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Authors' Reply To the Letters to the Editor by Puklin et al and by Iyengar and LigibelSamuel Martel, Matteo Lambertini, Evandro de Azambuja
Breast (Edinburgh, Scotland)|November 3, 2018
Reply to the letter "Safety of fertility preservation in women with breast cancer"Matteo Lambertini, Paola Anserini, Lucia Del Mastro
European Journal of Cancer (Oxford, England : 1990)|December 30, 2015
Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?Matteo Lambertini, Paola Anserini, Lucia Del Mastro
Pageof 38

Showing results (21-30 of 375) with videos related to

Sort By:
Pageof 38
Breast Cancer Research and Treatment|June 30, 2020
Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancerMarta Perachino, Francesca Poggio, Matteo Lambertini
Breast (Edinburgh, Scotland)|May 20, 2026
Neurokinin pathway antagonists for vasomotor symptoms in women with breast cancer: focus on elinzanetant and fezolinetantKatarzyna Pogoda, Luca Arecco, Matteo Lambertini
BJC Reports|September 20, 2025
Response to: Survival after risk-reducing mastectomy in young BRCA1 carriers with breast cancerVirginia Delucchi, Matteo Lambertini, Eva Blondeaux
Journal of Thoracic Disease|July 1, 2014
The burden of breast cancer from China to ItalyAlessia Levaggi, Francesca Poggio, Matteo Lambertini
Breast Cancer Research and Treatment|May 11, 2018
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapyFrancesca Poggio, Benedetta Conte, Matteo Lambertini
Current Opinion in Oncology|October 10, 2018
Impact of ovarian function suppression in premenopausal women with estrogen receptor-positive early breast cancerMatteo Lambertini, Giulia Viglietti, Evandro de Azambuja
NPJ Breast Cancer|March 17, 2023
Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancerElisa Agostinetto, Evandro de Azambuja, Matteo Lambertini
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Authors' Reply To the Letters to the Editor by Puklin et al and by Iyengar and LigibelSamuel Martel, Matteo Lambertini, Evandro de Azambuja
Breast (Edinburgh, Scotland)|November 3, 2018
Reply to the letter "Safety of fertility preservation in women with breast cancer"Matteo Lambertini, Paola Anserini, Lucia Del Mastro
European Journal of Cancer (Oxford, England : 1990)|December 30, 2015
Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?Matteo Lambertini, Paola Anserini, Lucia Del Mastro
Pageof 38